Follow the people · Insider

AM

Atabak Mokari

Insider · Chief Financial Officer · CORT

Atabak Mokari files insider transactions with the SEC as a chief financial officer of Corcept Therapeutics (CORT). We hold 4 disclosed purchases and sales filed since 29 July 2016, 3 of them in the last 90 days.

  • Files forCORT
  • Disclosed buys and sells4 in all, 3 in the last 90 days
  • Last disclosure3 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 1 March 20212 September 2026Chief Financial Officer · Corcept Therapeutics (CORT)85 Form 4 lines · source: SEC Form 4
  • Filed 19 December 20188 April 2020Chief Financial Officer · Bellicum Pharmaceuticals (BLCM)3 Form 4 lines · source: SEC Form 4
  • Filed 27 July 201611 December 2018CFO and VP Corp Development · Iridex (IRIX)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

95 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.